Results 171 to 180 of about 2,174,249 (299)

GENE-FUNCTION ANALYSIS OF CANDIDATE EFFECTOR PROTEINS OF WHEAT STRIPE RUST PATHOGEN

, 2013
GENE-FUNCTION ANALYSIS OF CANDIDATE EFFECTOR PROTEINS OF WHEAT STRIPE RUST ...
Akkaya, Mahinur, Dagvadorj, Bayantes
core  

Modulation of host functions by bacterial serine/threonine protein kinase effector proteins. [PDF]

J Biol Chem
Ge J, Qiu J.
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

A commensal bacterium secretes effector proteins to establish population heterogeneity in the gut. [PDF]

Cell Host Microbe
Zagieboylo AP, Mo R, Lim B, Goodman AL.
europepmc   +1 more source

High-throughput identification of Toxoplasma gondii effector proteins that target host cell transcription. [PDF]

Cell Host Microbe, 2023
Butterworth S, Kordova K, Chandrasekaran S, Thomas KK, Torelli F, Lockyer EJ, Edwards A, Goldstone R, Koshy AA, Treeck M.   +9 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Targeting effector proteins of plant pathogens as a strategy for durable plant disease resistance. [PDF]

Front Microbiol
Senthilraja G, Sandhya M, Priyadharshini E, Anand T, Kavitha M, Tharmalingam N.   +5 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Cyclized Peptide Inhibitors of the Small G Protein Cdc42 Mimic Binding of Effector Proteins. [PDF]

Biochemistry
Murphy NP, Tetley GJN, Revell J, Mott HR, Owen D.   +4 more
europepmc   +1 more source

Identification and Characterization of Novel Candidate Effector Proteins from Magnaporthe oryzae. [PDF]

J Fungi (Basel), 2023
Liu D, Lun Z, Liu N, Yuan G, Wang X, Li S, Peng YL, Lu X.   +7 more
europepmc   +1 more source